James Recabaren, MD
Surgery · Pasadena, CANPI 1851320063
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $30,035 of the $33,885 with a category attached, or 88.6%. Clarix Imaging Corporation accounts for 95.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $32,950 and has fallen 99.4% since, to $189 in 2025. Among surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $1882.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Clarix Imaging Corporation$32K
- BD$529
- TELA Bio, Inc.$468
- Vertex$125
- Portola Pharmaceuticals, LLC$123
- Acell, Inc.$96
- plus $94 from 3 others
What the payments were for
- Consulting fees$30,03589%
- Speaking & faculty fees$2,9799%
- Food & beverage$8713%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Clarix Imaging Corporation | 4 | $32,450 |
| BD | 2 | $529 |
| TELA Bio, Inc. | 6 | $468 |
| Vertex | 1 | $125 |
| Portola Pharmaceuticals, LLC | 1 | $123 |
| Acell, Inc. | 1 | $96 |
| Medtronic | 1 | $35 |
| Sientra, Inc. | 1 | $35 |
| Polynovo North America LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,885 in reported general payments places this provider in the 90th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $112 |
Paid to pharmacies, not to this prescriber.
Other surgery in Pasadena
- David LouriePasadena$1.4M
- Timothy ChuterSan Francisco$8.8M
- Santiago HorganSan Diego$2.8M
- Rock LiuHayward$1.6M
- Andrea PakulaThousand Oaks$1.4M
- Siew-Ming LeeFresno$1.3M
- Beemen KhalilPalo Alto$1.1M
- John LiphamLos Angeles$942K
- Alexander NedopilLodi$682K
- Barry GardinerSan Ramon$602K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.